SCHEMBL7470097

SCHEMBL7470097

c1cnc(-c2ccsc2)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 8/20 0.50
CYP2B6 P20813 3/20 0.50
CYP2E1 P05181 2/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
NPC1 O15118 1/20 0.47
PDGFRB P09619 2/20 0.43
PDGFRA P16234 2/20 0.43
CCNB2 O95067 1/20 0.42
CDK1 P06493 1/20 0.42
CCNB1 P14635 1/20 0.42
GSK3B P49841 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
CCNB3 Q8WWL7 1/20 0.42
CYP17A1 P05093 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
PPARA Q07869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9826781 0.79 CYP2A6 (0.48) CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9
SCHEMBL9826305 0.79 CDK5 (0.41) CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9
SCHEMBL19148272 0.77 CYP2A6 (0.50) CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9
SCHEMBL13977897 0.77 CYP2A6 (0.50) CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9
SCHEMBL29723603 0.76 KDM4E (0.52) CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9
SCHEMBL28666089 0.76 CYP2A6 (0.45) CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9
SCHEMBL597347 0.76 KDM4E (0.52) CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9
SCHEMBL8363952 0.76 CYP2A6 (0.40) CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9
SCHEMBL11166932 0.76 CDK5 (0.42) CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9
SCHEMBL30681814 0.76 BACE1 (0.46) CYP2A6CYP2B6CYP2E1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188068-A1 AMIDO CYCLOPROPYL DERIVATIVES AS LPA RECEPTOR INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2025-06-12 US disclosed
US-20240109842-A1 ACRYLAMIDE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-04-04 US disclosed
CN-114502551-B Fluorine-containing pyrimidine compound and preparation method thereof 优迈特株式会社 2023-08-22 CN disclosed
EP-4073038-A1 ACRYLAMIDE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2022-10-19 EP disclosed
CN-115181095-A Pyrimidine-based luminophor with fluorescence-delayed fluorescence-room temperature phosphorescence triple emission characteristics and preparation method thereof 天津大学 2022-10-14 CN disclosed
CN-114667280-A Acrylamide compound 大塚制药株式会社 2022-06-24 CN disclosed
CN-114502551-A Fluorine-containing pyrimidine compound and preparation method thereof 优迈特株式会社 2022-05-13 CN disclosed
WO-2021117733-A1 ACRYLAMIDE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2021-06-17 WO disclosed
EP-3555095-A1 INHIBITORS OF INFLUENZA VIRUS REPLICATION AND USES THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2019-10-23 EP disclosed
WO-2018108125-A1 INHIBITORS OF INFLUENZA VIRUS REPLICATION AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2018-06-21 WO disclosed
US-5747423-A HERBICIDES AMERICAN CYANAMID COMPANY (US) 1998-05-05 US disclosed
EP-0819690-A3 Herbicidal 6-thienyl and 4-thienyl pyrimidines American Cyanamid Company (US) 1998-03-04 EP disclosed
EP-0819690-A3 Herbicidal 6-thienyl and 4-thienyl pyrimidines American Cyanamid Company (US) 1998-03-04 EP disclosed
EP-0819690-A2 Herbicidal 6-thienyl and 4-thienyl pyrimidines American Cyanamid Company (US) 1998-01-21 EP disclosed
EP-0819690-A2 Herbicidal 6-thienyl and 4-thienyl pyrimidines American Cyanamid Company (US) 1998-01-21 EP disclosed
EP-0819690-A2 Herbicidal 6-thienyl and 4-thienyl pyrimidines American Cyanamid Company (US) 1998-01-21 EP disclosed
EP-0165753-B1 HERBICIDAL THIOPHENESULFONAMIDES AND PYRIDINESULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-12-11 EP disclosed
US-4723988-A PLANT GROWTH REGULATORS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-02-09 US disclosed
US-4684393-A PLATN GROWTH REGULATORS E. I. DUPONT DE NEMOURS AND COMPANY (US) 1987-08-04 US disclosed
EP-0165753-A2 Herbicidal thiophenesulfonamides and pyridinesulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1985-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250188068-A1 AMIDO CYCLOPROPYL DERIVATIVES AS LPA RECEPTOR INHIBITORS LPAR1, LPAR2, LPAR3 CYP2A6 2190/4885CYP2B6 2555/4885CYP2E1 2910/4885
US-20240109842-A1 ACRYLAMIDE COMPOUNDS HPGDS, MYADM, ACR CYP2A6 687/4885CYP2B6 1088/4885CYP2E1 355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.